Gesamtlänge aller Episoden: 3 days 23 hours 13 minutes
Unintentional weight loss in older adults (1:50), the top 20 research studies of 2020 (6:40), chronic obstructive pulmonary disease exacerbations (9:50), GeneSight (12:20), single-dose opioid analgesics (14:30), and rapid antigen and molecular tests...
Complex regional pain syndrome (1:40), pharmacologic management of agitation in dementia (5:20), semaglutide (7:10), clascoterone for acne (9:20), lung cancer screening (12:20), and management of infants born to mothers with HIV infection (13:50).
Care of the college student (1:40), fallacies and dangers of race-based medicine (4:40), intrauterine devices for heavy bleeding (6:50), pertussis (9:30), ultrasonography for small bowel obstruction (15:30), and COVID-19 postdischarge (17:30).
Human papillomavirus (1:40), state-level variation in primary care (5:30), dysmenorrhea (7:40), diverticulitis (11:00), physical activity to prevent depression (12:40), diabetes medications and cardiovascular outcomes (15:00).
Lower extremity cellulitis (1:30), Kawasaki disease (4:00), pelvic floor muscle training (8:20), parasitic infections (10:30), Helicobacter pylori infection treatment (16:50), and calprotectin in the evaluation of inflammatory bowel disease (19:50).
Hereditary hemochromatosis (1:30), remdesivir (5:00), race-based clinical algorithms (8:30), melatonin in older adults (10:50), alcohol withdrawal syndrome (13:40), and epidural corticosteroid injections (18:50).
Interventions to improve use of continuous positive airway pressure (1:30), onychomycosis (4:20), racial disparities at the end of life (8:30), osteomyelitis (10:10), diet and physical activity for cardiovascular disease prevention (15:10), and...
Hepatitis A (1:30), screening for ovarian cancer (5:30), refusing gifts from industry (8:00), diabetes-related foot infection (11:30), ultrasonography for peripheral intravenous catheters (16:40), and venous thromboembolism (18:30).
Vocal cord dysfunction (1:30), injections for trigger finger (3:50), Mycoplasma genitalium (5:40), fetal growth restriction (8:40), coenzyme Q10 (13:50), and dual antiplatelet therapy for stroke (17:00).
Altered mental status (1:30), treatment for migraines (6:10), tirbanibulin (9:40), basal cell carcinoma (13:10), end-stage renal disease (16:20), and antibiotic therapy in community-acquired pneumonia (21:40).